Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein - PubMed (original) (raw)
Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein
K Hong et al. Infect Immun. 1990 Aug.
Abstract
When Streptococcus pyogenes group A type 3 strain C203 (M+) and its M-protein-lacking derivative, strain C203S (M-), were treated with normal human serum in the presence of magnesium-EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid], virulent M+ bacteria bound only 10 to 30% as much C3 and factors B and P as did avirulent M- bacteria. After treatment of M+ bacteria with trypsin, which inactivates M protein, their binding of these substances was similar to that of M- bacteria. Pretreatment of M+ bacteria with the Fab fragment of rabbit immunoglobulin G anti-M antibody also increased their binding of C3 in the absence of Ca2+. Therefore, M protein inhibits the alternative C3 convertase. In contrast, in the presence of Ca2+ and Mg2+, M+ bacteria bound 75% as much C3 as M- bacteria. This binding was mostly mediated by classical pathway activation, because M+ bacteria bound much smaller amounts of factors B and P than did M- bacteria but consumed amounts of C4 and C2 comparable to those consumed by M- bacteria. On the other hand, the amount of C5 bound to M+ bacteria was much less than that bound to M- bacteria, and the consumption of C5 and C8 by M+ bacteria was also much less than that by M- bacteria. Therefore, M protein does not inhibit the classical C3 convertase but does inhibit the classical C5 convertase. When M+ and M- streptococci were incubated with normal human serum containing radiolabeled C3 in the presence of Ca2+ and Mg2+, more than 85% of the C3 bound to either type of streptococcus was extractable by sodium dodecyl sulfate and alkali treatment. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the C3 extracted from both strains showed that it was mostly C3b and iC3b. The proportions of C3b and iC3b, respectively, were 7.5 and 71.9% on M+ bacteria and 18.9 and 58.4% on M- bacteria. These results support and extend previous findings that the antiphagocytic activity of streptococcal M protein may be due to complement inhibition mediated by the binding of factor H.
Similar articles
- Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT. Fearon DT. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71. doi: 10.1073/pnas.76.11.5867. Proc Natl Acad Sci U S A. 1979. PMID: 293688 Free PMC article. - Regulation of C5 convertase activity by properdin, factors B and H.
Weiler JM. Weiler JM. Immunol Res. 1989;8(4):305-15. doi: 10.1007/BF02935515. Immunol Res. 1989. PMID: 2531781 No abstract available. - A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
Waldo FB, Forristal J, Beischel L, West CD. Waldo FB, et al. J Clin Invest. 1985 Jun;75(6):1786-95. doi: 10.1172/JCI111891. J Clin Invest. 1985. PMID: 3159752 Free PMC article. - Activation of the alternative complement pathway.
Fearon DT. Fearon DT. CRC Crit Rev Immunol. 1979 Nov;1(1):1-32. CRC Crit Rev Immunol. 1979. PMID: 162484 Review. No abstract available. - Complement Factor H related protein 1 and immune inflammatory disorders.
Li X, Zong J, Si S. Li X, et al. Mol Immunol. 2022 May;145:43-49. doi: 10.1016/j.molimm.2022.03.117. Epub 2022 Mar 11. Mol Immunol. 2022. PMID: 35279539 Review.
Cited by
- Expression of the Group A Streptococcus Fibrinogen-Binding Protein Mrp Is Negatively Regulated by the Small Regulatory RNA FasX.
Danger JL, Roshika R, Baral S, Sumby P. Danger JL, et al. J Bacteriol. 2022 Nov 15;204(11):e0025122. doi: 10.1128/jb.00251-22. Epub 2022 Oct 26. J Bacteriol. 2022. PMID: 36286516 Free PMC article. - Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions.
Swe PM, Christian LD, Lu HC, Sriprakash KS, Fischer K. Swe PM, et al. PLoS Negl Trop Dis. 2017 Mar 9;11(3):e0005437. doi: 10.1371/journal.pntd.0005437. eCollection 2017 Mar. PLoS Negl Trop Dis. 2017. PMID: 28278252 Free PMC article. - Characterization of group a streptococcal M23 protein and comparison of the M3 and M23 protein's ligand-binding domains.
Hong K. Hong K. Curr Microbiol. 2007 Nov;55(5):427-34. doi: 10.1007/s00284-007-9012-9. Epub 2007 Sep 4. Curr Microbiol. 2007. PMID: 17768657 - M(+) group a streptococci are phagocytized and killed in whole blood by C5a-activated polymorphonuclear leukocytes.
DeMaster E, Schnitzler N, Cheng Q, Cleary P. DeMaster E, et al. Infect Immun. 2002 Jan;70(1):350-9. doi: 10.1128/IAI.70.1.350-359.2002. Infect Immun. 2002. PMID: 11748201 Free PMC article. - BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.
Barnes MG, Weiss AA. Barnes MG, et al. Infect Immun. 2001 May;69(5):3067-72. doi: 10.1128/IAI.69.5.3067-3072.2001. Infect Immun. 2001. PMID: 11292725 Free PMC article.
References
- J Infect Dis. 1979 May;139(5):575-85 - PubMed
- J Immunol. 1979 Mar;122(3):759-65 - PubMed
- J Immunol. 1979 Jun;122(6):2418-23 - PubMed
- J Immunol. 1979 Aug;123(2):529-34 - PubMed
- J Immunol. 1980 Feb;124(2):602-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous